查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750775

口服固體製劑契約製造市場規模、佔有率、趨勢分析報告：按產品、機制、最終用途、地區、細分市場預測，2025-2030 年

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Tablets, Capsules, Powders, Granules), By Mechanism (Controlled Release, Immediate Release), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 178 Pages | 商品交期: 2-10個工作天內

價格

口服固體製劑契約製造市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球口服固體製劑契約製造市場規模預計到2030年將達到547.2億美元，2025年至2030年的複合年成長率為5.99%。

新藥分子日益複雜、大型 CMO 和 CDMO 的研發投資以及對新療法的需求不斷成長是推動市場成長的主要因素。

口服固體製劑因其成本效益高、易於生產且患者友善等特點，在製藥業廣受歡迎。此外，控制釋放和緩釋製劑等藥物傳遞技術的進步，使得口服固體製劑能達到更高的生物有效性度，同時降低給藥頻率。這有望推動市場成長潛力。

口服固體製劑開發和大量生產技術的進步是此類產品快速商業化的主要因素之一。目前，市面上有各種各樣的劑型。然而，營養保健品和製藥業始終專注於口服固體製劑（OSD）劑型的開發，因為其易於操作、服用方便且患者依從性良好。 OSD製劑技術和材料的蓬勃發展預計將推動對此類製劑的需求。

此外，CMO/CDMO的研發投入正在促進生產流程、製劑開發和分析技術的創新。這有助於在口服固體製劑的生產中採用更有效率、更先進的生產技術。研發投入還能提高生產能力和可擴充性，使CMO/CDMO能夠提供更多口服固體製劑，以滿足製藥公司日益成長的需求。

此外，該產業在 2023 年出現了許多策略性舉措，包括聯盟、夥伴關係、併購和服務擴展。

  • 2023年7月，Aenova集團與Galvita建立策略夥伴關係，以改善口服藥物的配方、生產和開發。
  • 2023 年 4 月，Aenova 投資約 2,196 萬美元（2,000 萬歐元）擴建其位於蒂特莫寧的散裝固態劑量生產基地，以提高生產能力。
  • 2023 年 1 月，Catalent 和 Ethicann 合作，利用 Catalent 的口溶錠(ODT) 技術開發 Ethicann 的臨床藥物管線。

口服固體製劑契約製造市場報告重點

  • 2024年，錠劑市場佔據主導地位，收入佔有率達32.74%。錠劑因其成本效益高、結構緊湊、易於生產和方便自行服用等特點，成為最常見且最受歡迎的口服緩釋片 (OSD) 劑型。雙層片劑需求的不斷成長，以及企業在擴大製劑配方和控制釋放錠劑生產方面的投資，預計將推動市場成長。
  • 控制釋放錠劑市場在2024年佔據了最大的佔有率。這一成長可歸因於口服控制釋放給藥系統（例如圓頂片、雙劑量錠劑、腸道貼片、聚合物奈米系統）以及仿生給藥方法（例如用於精準藥物遞送的外泌體）的進步。因此，對控制釋放劑型的旺盛需求預計將在不久的將來推動該市場的收益成長。
  • 從最終用途來看，大型企業在2024年佔據了最大的佔有率。固態劑型製造市場日益以協作、靈活性和高適應性為特徵。越來越多的製藥開發公司打算從零開始設計藥物，並將其委託給領先的CMO，從而加速市場成長。此外，專門從事口服固體製劑的CMO正受到越來越多的青睞，因為它們可以為大型製藥企業帶來許多益處。
  • 預計亞太地區將在2024年引領全球市場，並在預測期內實現最快的複合年成長率。中國和印度是口服固體製劑契約製造的強國，且價格明顯較低。此外，新加坡、印度和韓國等亞洲國家由於生產能力不斷提升，被視為製藥業的主要參與者。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術格局
    • 製造技術
    • 封裝技術
    • 塗層技術
    • 包裝技術
    • 分析技術
  • 定價模式分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章口服固體製劑契約製造市場：產品評估與趨勢分析

  • 細分儀表板
  • 口服固體製劑契約製造市場：產品差異分析
  • 口服固體製劑契約製造市場規模及趨勢分析（依產品，2018-2030 年）
  • 藥片
  • 膠囊
  • 粉末
  • 顆粒
  • 其他

第5章口服固體製劑契約製造市場：機制評估與趨勢分析

  • 細分儀表板
  • 口服固體製劑契約製造市場：機制波動分析
  • 口服固體製劑契約製造規模及趨勢分析（依機制，2018-2030）
  • 即時釋放
    • 延遲釋放
    • 控釋

第6章口服固體製劑契約製造市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 口服固體製劑契約製造市場：最終用途差異分析
  • 2018-2030年口服固體製劑契約製造規模及趨勢分析（依最終用途）
  • 主要企業
  • 中小企業
  • 其他

第7章口服固體製劑契約製造市場：按地區分類的業務分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭態勢

  • 公司分類
  • 2024年企業市場分析
  • 公司簡介
    • Catalent, Inc.
    • Lonza
    • Aenova Group
    • Boehringer Ingelheim International GmbH
    • Jubilant Pharmova Limited
    • Patheon Pharma Services
    • Recipharm AB.
    • Corden Pharma International
    • Siegfried Holding AG
    • Piramal Pharma Solutions
    • AbbVie Contract Manufacturing
    • Next Pharma AB
Product Code: GVR-4-68039-948-4

Oral Solid Dosage Contract Manufacturing Market Growth & Trends:

The global oral solid dosage contract manufacturing market size is estimated to reach USD 54.72 billion by 2030, registering a CAGR of 5.99% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.

  • In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
  • In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
  • In January 2023, Catalent and Ethicann collaborated to develop Ethicann's clinical drug pipeline using Catalent's technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights:

  • The tablets segment dominated the market with a revenue share of 32.74% in 2024. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth.
  • The controlled release segment accounted for the largest share in 2024. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future.
  • Based on end-use, the large size companies segment accounted for the largest share in 2024. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption.
  • Asia Pacific led the global market in 2024 and is projected to witness the fastest CAGR over the forecast period. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Information Analysis
    • 1.4.2. Market Formulation & Data Visualization
    • 1.4.3. Data Validation & Publishing
  • 1.5. Model Details
    • 1.5.1. Commodity Flow Analysis (Model 1)
    • 1.5.2. Top Down Market Estimation (Model 2)
    • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
    • 1.5.4. Multivariate Analysis (Model 4)
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
      • 3.3.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
      • 3.3.1.3. Increasing Demand for Novel Therapies
      • 3.3.1.4. Increasing Demand for One-Stop-Shop CMOs
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Strict Approval Criteria by Regulatory Authorities
      • 3.3.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
      • 3.3.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
  • 3.4. Technology Landscape
    • 3.4.1. Manufacturing Technology
    • 3.4.2. Encapsulation Technology
    • 3.4.3. Coating Technology
    • 3.4.4. Packaging Technology
    • 3.4.5. Analytical Technology
  • 3.5. Pricing Model Analysis
  • 3.6. Industry Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Oral Solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Oral Solid Dosage Contract Manufacturing Market; Product Movement Analysis
  • 4.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Tablets
    • 4.4.1. Tablets market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Capsules
    • 4.5.1. Capsules market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Powders
    • 4.6.1. Powders market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Granules
    • 4.7.1. Granules market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Oral Solid Dosage Contract Manufacturing Market: Mechanism Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Oral Solid Dosage Contract Manufacturing Market; Mechanism Movement Analysis
  • 5.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
  • 5.4. Immediate Release
    • 5.4.1. Immediate release market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Delayed Release
      • 5.4.2.1. Delayed release market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Controlled Release
      • 5.4.3.1. Controlled release market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Oral Solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Oral Solid Dosage Contract Manufacturing Market; End Use Movement Analysis
  • 6.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Large Size Companies
    • 6.4.1. Large size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Medium & Small Size Companies
    • 6.5.1. Medium & small size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Oral Solid Dosage Contract Manufacturing Market: Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Mexico oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. UK oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. France oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. China oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. India oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Brazil oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Argentina oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. South Africa oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Saudi Arabia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. UAE oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Kuwait oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Catalent, Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Lonza
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Aenova Group
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Boehringer Ingelheim International GmbH
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Jubilant Pharmova Limited
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Patheon Pharma Services
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Recipharm AB.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Corden Pharma International
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Siegfried Holding AG
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Piramal Pharma Solutions
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. AbbVie Contract Manufacturing
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Service benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Next Pharma AB
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Service benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Oral Solid Dosage Contract Manufacturing Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 North America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 5 North America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 8 U.S. Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Canada Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 Canada Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 11 Canada Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 Mexico Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 14 Mexico Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Europe Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 18 Europe Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 UK Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 21 UK Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Germany Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 24 Germany Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 France Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 France Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 27 France Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28 Italy Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Italy Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 30 Italy Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Spain Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Spain Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 33 Spain Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Denmark Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 36 Denmark Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Sweden Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 39 Sweden Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Norway Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Norway Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 42 Norway Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 China Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 China Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 49 China Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 India Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 India Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 52 India Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Japan Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 55 Japan Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Australia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Australia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 58 Australia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 61 South Korea Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Thailand Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 64 Thailand Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Latin America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 68 Latin America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 70 Brazil Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 71 Brazil Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 74 Argentina Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
  • Table 76 MEA Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 MEA Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 78 MEA Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 81 South Africa Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 85 UAE Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 UAE Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 87 UAE Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Oral solid dosage contract manufacturing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Market formulation & validation
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2024 (USD Million)
  • Fig. 16 Ancillary market outlook, 2024 (USD Million)
  • Fig. 17 Oral solid dosage contract manufacturing market dynamics
  • Fig. 18 Product approvals in the U.S. and EU per year (2024)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Oral solid dosage packaging types in the U.S., 2024 (volume percentage share %)
  • Fig. 22 Oral solid dosage blister packaging types in the U.S., 2024 (volume percentage share %)
  • Fig. 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
  • Fig. 24 Oral solid dosage contract manufacturing market: Product type movement analysis
  • Fig. 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
  • Fig. 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
  • Fig. 32 Immediate release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Delayed release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Controlled release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
  • Fig. 36 Oral solid dosage contract manufacturing market: End-use movement analysis
  • Fig. 37 Large size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Medium & small size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 Regional outlook, 2024 & 2030
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 North America market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Regulatory bodies in India involved in pharmaceutical regulations
  • Fig. 70 India oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Clinical trial authorization process in Japan
  • Fig. 73 Clinical Research of Medical Products in Japan
  • Fig. 74 Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 78 Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Clinical trial approval process in South Korea
  • Fig. 81 South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Clinical trial authorization process UAE
  • Fig. 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)